Clinical Trial: Study of the Impact on Survival of a Paradigm Shift in the Therapeutic Strategy of Patients With Advanced Ovarian Cancer

U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT06907771) titled 'Study of the Impact on Survival of a Paradigm Shift in the Therapeutic Strategy of Patients With Advanced Ovarian Cancer' on March 26.

Brief Summary: Ovarian cancer is the 8th leading cause of cancer-related death in women. Its prognosis is poor, with diagnosis often made at an advanced stage.

Patient management has evolved in recent years with more radical surgeries and the introduction of maintenance treatment following neoadjuvant chemotherapy.

Study Start Date: April 22, 2024

Study Type: OBSERVATIONAL

Condition: Ovarian Cancer

Recruitment Status: RECRUITING

Sponsor: University Hospital, Strasbourg, France

Published by HT...